Can a blood filtering therapy tame type 1 diabetes?
NCT ID NCT05413005
First seen Jan 04, 2026 · Last updated May 13, 2026 · Updated 24 times
Summary
This pilot study tests a treatment called extracorporeal photopheresis (ECP) in 10 adults with type 1 diabetes. ECP filters and treats a patient's blood with light and a drug, then returns it, aiming to calm the immune attack on the pancreas. The goal is to see if ECP is safe and can reduce insulin needs and improve blood sugar control, but it is not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abu Dhabi Stem Cells Center
Abu Dhabi, Abu Dhabi Emirate, 4600, United Arab Emirates
Conditions
Explore the condition pages connected to this study.